The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...

The US Food and Drug Administration (FDA) rejected three prior regulatory applications before granting approval.

The USPTO has granted a patent to Vistagen’s non-opioid oral product candidate AV-101 for neuropathic pain treatment.

X-Elio will supply 245GWh of clean energy annually to four pharmaceutical companies through its Lorca Solar project.

EVA Pharma of Africa, DNA Script and Quantoom Biosciences have signed a MoU to establish the mRNA production platform in Egypt.

Experts at the 2025 Clinical Trial Supply Europe conference will explore supply chain challenges and the impact of AI on ...

While vaccine sales dropped, GSK raised its revenue guidance for 2031 with speciality medicines expected to drive that growth ...

The last few days have been a rollercoaster for the pharmaceutical industry. Mexico and Canada were bracing themselves for ...

Jabil has acquired contract development and manufacturing organisation (CDMO) Pharmaceutics International (Pii).

MedPharm has appointed Bill Humphries as its new CEO, marking a significant step in the company's strategic growth.

Developers celebrate gains for advances with radiopharmaceuticals while regulators and isotope suppliers work to keep up.

Valneva’s chikungunya vaccine Ixchiq has been greenlit by the UK’s MHRA, allowing the single-dose vaccine to be made ...